Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Completes $21.5M SciTegic Acquisition

NEW YORK, Sept. 28 (GenomeWeb News) - Accelrys said today that it has completed its acquisition of research workflow software firm SciTegic.in a deal worth approximately $21.5 million.

 

The deal, which was announced earlier this month, will see SciTegic become a wholly owned subsidiary of Accelrys, which plans to incorporate SciTegic's Pipeline Pilot software into its portfolio.

 

Both companies are based in San Diego, Calif. SciTegic said that it plans to remain there, and that Matt Hahn, co-founder and CEO of the SciTegic, will continue to manage the subsidiary's operations while reporting to Mark Emkjer, Accelrys' CEO.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.